Detect potential diversion earlier to improve safety and compliance

Despite 98% of healthcare executives agreeing that drug diversion occurs in hospitals, 79% believe that most drug diversion goes undetected. With Sentri7®, detect drug diversion, bolster controlled substance compliance, and track medication inventory.

Sentri7 Drug Diversion (formerly Flowlytics from Invistics) is the only drug diversion software funded by the NIH 

Utilizing machine learning, Sentri7 enables quick detection of potential diversion from purchase to the patient with predictive analytics and actionable dashboards. Sentri7 integrates data from multiple IT systems including Automated Dispensing Cabinet (ADC), Electronic Health Records (EHR), and other data systems to provide a comprehensive assessment of diversion risk across the entire supply chain.

Monitor and compare high-risk populations easily

HEAT™ score shows the cumulative risk of an individual compared to peers to uncover diversion quickly. Display risky transactions for a single clinician in a comprehensive Investigation Dashboard.

Automate early and accurate alerts from purchase to patient

Machine learning and advanced analytics achieve over 90% alert accuracy and reduce false positives. Configure alerts to facility policies and procedures. Save time with an easy-to-use dashboard and reports.

Detect diversion of controlled and non-controlled substances

Track any medication for diversion monitoring, including costly high-risk drugs like oncology and antiviral biologics, and frequently diverted non-controlled medications.

Detect drug diversion earlier, ease reporting, and effectively manage inventory.

Learn how advanced analytics can support your pharmacy teams in sifting through data to provide answers in near real-time.

Speak To An Expert

The State of Drug Diversion 2025 Report

The State of Drug Diversion Report offers a comprehensive view of hospital practices from the perspective of executives, pharmacists, and drug diversion specialists, revealing key trends, challenges, and opportunities in the fight against drug diversion.

2025 Report

Drug diversion detection best practices

group walking in hallway

DEA expectations and best practices for drug diversion investigations

Learn how to investigate suspected diversion in your healthcare facility, including how to collect and retain evidence, compile your investigation notes, and document the results of your investigation.

View Webinar
pharmacy inventory

Preventing drug diversion in your healthcare facility

Review the latest strategies to help healthcare organizations develop and implement a collaborative, comprehensive, controlled substance diversion prevention program.

Download The Guidelines
Pharmacist in pharmacy

Drug diversion study using machine learning and advanced analytics

In 2022, the American Journal of Health-System Pharmacy published a research study to develop a test for novel drug diversion detection methods. Improved diversion detection and reduction in diversion improves patient safety, limits harm to the person diverting, reduces the public health impact of a substance use disorder, and mitigates significant liability risk to pharmacists and their organizations.

View Study

Want more information on how Drug Diversion can help you detect potential diversion earlier, ease reporting, and manage inventory more effectively?

Complete the form and we'll be in contact with you soon.

Expert insights related to Sentri7 Drug Diversion

Back To Top